Keywords: Germany, Drug pricing, Reforms, Health costs, AVR, AOK, BPI, AMNOG

German drug pricing reforms lower health system’s costs, says AVR report

Article | 23 September 2011

The multi-year uptrend in drug expenditure by Germany’s health insurers could be ending, according to the latest Arzneiverordnungs ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in